We are developing processes and tools to assess the safety of anti-amyloid therapies for Alzheimer's Disease using real world data (PI: Dr. Gurwitz).
Students will learn the data entry process for validation and clinical epidemiology on how to measure PPVs and have the opportunity to participate in presentations/publications.